Comparing Apollo Medical (AMEH) and Its Competitors

Apollo Medical (NASDAQ: AMEH) is one of 29 publicly-traded companies in the “Management consulting services” industry, but how does it compare to its competitors? We will compare Apollo Medical to similar companies based on the strength of its institutional ownership, earnings, valuation, analyst recommendations, risk, dividends and profitability.

Profitability

This table compares Apollo Medical and its competitors’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Apollo Medical 2.08% 6.00% 2.06%
Apollo Medical Competitors -20.25% -9.46% -10.88%

Analyst Recommendations

This is a breakdown of current ratings and price targets for Apollo Medical and its competitors, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Apollo Medical 0 0 1 0 3.00
Apollo Medical Competitors 160 489 665 40 2.43

Apollo Medical currently has a consensus target price of $25.00, indicating a potential upside of 30.89%. As a group, “Management consulting services” companies have a potential upside of 16.15%. Given Apollo Medical’s stronger consensus rating and higher possible upside, research analysts plainly believe Apollo Medical is more favorable than its competitors.

Valuation and Earnings

This table compares Apollo Medical and its competitors revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Apollo Medical $519.91 million $10.84 million 65.86
Apollo Medical Competitors $1.71 billion $120.52 million 26.75

Apollo Medical’s competitors have higher revenue and earnings than Apollo Medical. Apollo Medical is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry.

Institutional & Insider Ownership

6.7% of Apollo Medical shares are held by institutional investors. Comparatively, 62.2% of shares of all “Management consulting services” companies are held by institutional investors. 20.5% of Apollo Medical shares are held by company insiders. Comparatively, 13.6% of shares of all “Management consulting services” companies are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Volatility and Risk

Apollo Medical has a beta of -1.17, meaning that its share price is 217% less volatile than the S&P 500. Comparatively, Apollo Medical’s competitors have a beta of 1.08, meaning that their average share price is 8% more volatile than the S&P 500.

Summary

Apollo Medical beats its competitors on 8 of the 13 factors compared.

Apollo Medical Company Profile

Apollo Medical Holdings, Inc., an integrated health care delivery and management company, provides medical care services. The company offers care coordination services to principal constituents of the healthcare delivery system, including patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. Its physician network consists of primary care physicians, specialist physicians, and hospitalists. The company serves the patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organizations; and non-insured patients in California. Apollo Medical Holdings, Inc. is based in Alhambra, California.

Receive News & Ratings for Apollo Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Apollo Medical and related companies with MarketBeat.com's FREE daily email newsletter.